Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

BACKGROUND: Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined. METHODS: Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Particip...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:ERJ Open Res
मुख्य लेखकों: Gibson, Peter G., Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine, Peters, Matthew J., Marks, Guy B., Baraket, Melissa, Powell, Heather, Simpson, Jodie L.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: European Respiratory Society 2019
विषय:
Original Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6926362/
https://ncbi.nlm.nih.gov/pubmed/31886156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00056-2019
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन